Author:
Goldberg David S.,Olthoff Kim M.
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Nephrology,Hepatology,Immunology,Surgery
Reference28 articles.
1. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70.
2. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–6.
3. Goldberg D, Bittermann T, Makar G. Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant. 2012;12(6):1603––1609. This study explores the use of MELD exceptions for patients with PSC and bacterial cholangitis, and the lack of standardization of the review process.
4. Goldberg DS, Makar G, Bittermann T, Benjamin F. Center variation in the use of non-standardized MELD exception points. Liver Transpl. 2013. This study examines the variability in the use and approval of MELD exceptions between liver transplant centers within each UNOS region.
5. Freeman Jr RB, Gish RG, Harper A, et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl. 2006;12(12 Suppl 3):S128–36.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献